Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-0738
    Keywords: Chenodeoxycholic acid ; Chimpanzee ; Conjugation ; Lithocholic acid ; Sulfation ; Toxicity
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Um im Schimpansen die hepatische Biotransformation der primären Gallensäure Chenodeoxycholsäure und deren wichtigstem bakteriellen Metaboliten, Lithocholsäure zu charakterisieren, wurde ein Gemisch aus Spurenmengen von14C-Lithocholsäure und3H-Chenodeoxycholsäure intravenös in zwei Tiere mit Gallenfistel injiziert. Die chemische Form der Radioaktivität, die in der Galle erschien, wurde dünnschichtchromatographisch ermittelt. Etwa 80% der Chenodeoxycholsäure und 70% der Lithocholsäure wurden innerhalb von 90 min ausgeschieden. Die Chenodeoxycholsäure war vollständig konjugiert und erschien vorwiegend als Chenyltaurin (52%) und Chenylglycin (37%). 11% erschienen in einer Form, die bisher nicht identifiziert wurde. Lithocholsäure wurde vollständig als Taurin- und Glycinkonjugat in die Galle eliminiert; der größte Teil (63%) war zusätzlich sulfatiert. Die Sulfatierung nahm stetig mit der Zeit zu und Lithocholylglycine wurde stärker sulfatiert als Lithocholyltaurin. Wir schließen aus diesen Befunden, daß der Schimpanse mit dem Menschen vergleichbar ist, indem er Lithocholsäure effektiv sulfatiert. Dadurch unterscheidet sich der Schimpanse vom Rhesusaffe und Baboon, die die Lithocholsäure nur in geringem Maße sulfatieren. Jedoch unterscheidet sich der Schimpanse auch vom Menschen und ähnelt dem Rhesusaffen und dem Baboon, indem er Gallensäure vorwiegend mit Taurin konjugiert. Die Ergebnisse lassen den Schluß zu, daß die Hepatotoxizität, die im Rhesusaffe und Baboon durch Chenodeoxycholat hervorgerufen wird, und auf eine geringe Sulfatierung der Lithocholsäure zurückgeführt wird, beim Schimpansen nicht bestehen sollte.
    Notes: Abstract To characterize the hepatic biotransformation in the chimpanzee of the primary bile acid chenodeoxycholic acid (chenic) and its major bacterial metabolite lithocholic acid (lithocholic) a mixture of tracer amounts of14C-lithocholic and3H-chenic was injected intravenously into two animals with a bile fistula; the chemical form of radioactivity appearing in bile was inferred using thin layer chromatography. About 80% of chenic, and 70% of lithocholic was recovered in 90 min. Chenic was completely conjugated in bile, appearing predominantly as chenyltaurine (52%) and chenylglycine (37%). An unidentified conjugate (about 11%) was also found. Lithocholic was excreted completely as taurine and glycine conjugates, but the majority (63%) of conjugates was sulfated. Sulfation increased progressively with time, and lithocholylglycine was sulfated more than lithocholyltaurine. We conclude that the chimpanzee is similar to man in that the secondary bile acid lithocholic is efficiently sulfated. The chimpanzee thus differs from the baboon and rhesus monkey which sulfate lithocholic poorly. However, the chimpanzee differs from man and is similar to the baboon and rhesus monkey in showing preferential conjugation of bile acids with taurine. The results imply that hepatotoxicity caused by chenic, which is well documented in the rhesus monkey and baboon and has been related to defective lithocholic sulfation, should not occur in the chimpanzee.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-0738
    Keywords: Key words Polychlorinated dibenzodioxins  ;   2 ; 3 ; 7 ; 8-Tetrachlorodibenzo-p-dioxin ; Polychlorinated dibenzofuranes ; Toxicokinetics ; Infant Human ; Adipose tissue ; Liver
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Contents of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and of 16 further congeners – polychlorinated dibenzodioxins and dibenzofuranes (PCDD/PCDF) – were determined in lipids of adipose tissue and of livers of 3 stillborns and of 17 infants (0.43–44 weeks old) who died from sudden infant death syndrome. International toxic equivalents (I-TEq) calculated for the sum of TCDD together with all of the 16 congeners (1.55–29.63 ng/kg lipids of adipose tissue, n = 20; 2.05–57.73 ng/kg liver lipids, n = 19) were within the range of or lower than the values published for adults. TCDD concentrations in lipids of breast-fed infants were higher (0.38–4.1 ng/kg lipids of adipose tissue, n = 9; 0.49–3.9 ng/kg liver lipids, n = 8) compared to non breast-fed subjects (0.16–0.76 ng/kg lipids of adipose tissue, n = 8; 0.29–0.71 ng/kg liver lipids, n = 7). Neither I-TEq values nor TCDD concentrations exceeded values published for adults. Since even in stillborns PCDD/PCDF were found (I-TEq, 9.70–10.83 ng/kg lipids of adipose tissue, 6.17–8.83 ng/kg liver lipids; TCDD, 1.3–2.1 ng/kg lipids of adipose tissue, 0.76–1.5 ng/kg liver lipids; n = 3), transplacental exposure has to be deduced. All of the findings concerning TCDD concentrations in the organism become intelligible on the basis of a physiological toxicokinetic model which was developed to describe the body burden of TCDD for the entire human lifetime in dependence of TCDD uptake from contaminated nutrition. The model reflects sex and age dependent changes in the following parameters: body weight, volumes of liver, adipose and muscle tissue, food consumption, and excretion of faeces. TCDD is supposed to be taken up orally, to be distributed freely in lipids of the organism and to be eliminated unchanged by excretion in lipids of faeces as well as by metabolism in the liver. The model was used to predict the half-life of elimination of TCDD (4 months in newborns increasing to ∼5 years in adults) and concentrations of this compound in lipids of adipose tissue, blood, liver and faeces at different ages. Furthermore, the influence of breast-feeding on the TCDD burden of a mother, her milk and her child was simulated. The model was validated by means of own data gained in adipose tissue and livers of infants and also using a series of values measured by other authors in mother's milk and in tissues and faeces of infants and adults. Predictions as well as experimental findings demonstrate a distinct increase in the TCDD body burden of breast-fed infants. Generally, it can be concluded for the excretion of unchanged, non volatile, non protein bound highly lipophilic compounds that their half-life is short in infants (∼5 months) and increases to ∼10 years reached between 40 and 60 years of age.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 261 (1968), S. 152-161 
    ISSN: 1432-1912
    Keywords: Kidney Microsomes ; Phenobarbital ; Stimulation ; Cytochromes ; Drug Metabolism ; Nierenmikrosomen ; Phenobarbital ; Stimulierung ; Cytochrome ; Arzneimittel-Stoffwechsel
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Pretreatment of rats and rabbits with Phenobarbital (80 mg/kg and 60 mg/kg respectively) caused a 30% increase in the liver weight relative to body weight. There was a smaller increase in the kidney weight (7% in rats and 10% in rabbits) which was not statistically significant. The yields of microsomes per gram of liver was also increased by about 90% and 60% in rats and rabbits respectively, but only a slight increase was observed for kidneys (12% and 18% respectively). Pretreatment with Phenobarbital, 3,4-Benzpyrene or Chlorophenothane neither significantly increased the cytochromes of rat kidney microsomes, nor the oxidative drug metabolism. However, in the kidneys of rabbits the cytochrome-b5-and P450-concentrations and drug metbolism were 2–3 fold higher after Phenobarbital. The correlation between P450 content and drug oxidase activity in the kidney microsomes of untreated and Phenobarbital treated rabbits was low. Suspensions of rabbit kidney microsomes revealed the same spectral changes after addition of Hexobarbital or Aniline as those reported for liver microsomes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...